/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Our Company References to we, us, our, or the Company refer to BrightSpire Capital, Inc., a Maryland corporation, together with its consolidated subsidiaries, unless the context specifically requires otherwise. References to the OP refer to BrightSpire Capital Operating Company, LLC a Delaware limited liability company, the operating company of the Company.
$4.64
$0.11 (-2.32%)
EOD Sep 1, 2026
20.95% operating margin is above average. ROIC at 1.57%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 7.9% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 43% versus the prior year, cash generation momentum has weakened. Net debt of $2.42B represents 44.0x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$336M
▼ -7.9% YoY
Net Income (TTM)
-$23M
▲ +76.4% YoY
Op. Margin
28.67%
▲ +15.6pp YoY
ROIC
2.21%
▲ +1.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$74M
▼ -43.4% YoY
Op. Cash Flow (TTM)
$85M
▼ -29.4% YoY
Net Debt
$2.69B
Cash & Equiv.
$68M
5Y CAGR: +9.2%
5Y CAGR: -5.5%
Continue Research
SourceComputed from the 10-Q filed 29 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 30 Jul 2026. How this is calculated.
Price from market data, last close as of 1 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
BrightSpire Capital (BRSP) trades above a two-stage DCF intrinsic value of about $-11.15 per share, so at $4.64 the stock looks overvalued (340.2% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, BrightSpire Capital scores 26/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 14.3%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $-11.15 per share for BRSP, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $-8.36. At today's $4.64, that puts the stock about 340.2% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
BrightSpire Capital scores 26 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 28.7% operating margin and a 2.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, BrightSpire Capital pays a regular dividend of about $0.66 per share per year (typically in quarterly installments), a yield of roughly 14.3% at the current price. BrightSpire Capital has grown the dividend at roughly 12.4% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For BRSP's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. BRSP currently trades above its estimated intrinsic value and scores 26/100 on quality (lower-quality). It also yields about 14.3%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.